Trial Profile
A Double-blind, Multicenter, Randomized Phase 2a Study to Evaluate Optimum Dosage and Stability of DW-3101 in Korean Patients With Gastric Inflammation
Status:
Not yet recruiting
Phase of Trial:
Phase II
Latest Information Update: 09 Oct 2018
Price :
$35
*
At a glance
- Drugs DW 3101 (Primary)
- Indications Gastritis
- Focus Therapeutic Use
- Sponsors Daewon Pharmaceutical
- 11 Oct 2016 Planned primary completion date changed from 1 Jul 2015 to 1 Jul 2017.
- 17 Mar 2015 New trial record